BRAF and neuroendocrine carcinoma: Compared with colorectal adenocarcinomas, neuroendocrine carcinomas exhibited a higher frequency of BRAF (37%) mutations, but a lower frequency of KRAS (21%) and APC (16%) mutations [334].